1. Clopidogrel pharmacogenetics: Beyond candidate genes and genome‐wide association studies. Issue 3 (22nd November 2016) Authors: Lewis, JP; Shuldiner, AR Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 3(2017) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Educational innovations in clinical pharmacogenomics. Issue 6 (7th April 2016) Authors: Perry, CG; Maloney, KA; Beitelshees, AL; Jeng, LJB; Ambulos, NP; Shuldiner, AR; Blitzer, MG Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 6(2016:Jun.) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0228 Ugt1a1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab. (15th June 2017) Authors: Damask, A; Boyapati, A; Hamilton, JD; Hamon, S; Paccard, C; Parrino, J; Adelsberg, J van; Graham, NM; Penn, J; Lopez, A; Reid, J; Overton, J; Baras, A; Shuldiner, AR; Paulding, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identifying clinically relevant sources of variability: The clopidogrel challenge. Issue 2 (11th October 2016) Authors: Samant, S; Jiang, XL; Peletier, LA; Shuldiner, AR; Horenstein, RB; Lewis, JP; Lesko, LJ; Schmidt, S Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 2(2017) Page Start: 264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability. (16th July 2014) Authors: Ellero‐Simatos, S; Lewis, JP; Georgiades, A; Yerges‐Armstrong, LM; Beitelshees, AL; Horenstein, RB; Dane, A; Harms, AC; Ramaker, R; Vreeken, RJ; Perry, CG; Zhu, H; Sànchez, CL; Kuhn, C; Ortel, TL; Shuldiner, AR; Hankemeier, T; Kaddurah‐Daouk, R Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 7(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0179 The ASP358ALA variant in the IL6R gene is significantly associated with differences in soluble IL-6R protein levels but not with differences in sarilumab response in rheumatoid arthritis (RA) patients. (15th June 2017) Authors: Damask, A; Boyapati, A; Hamilton, JD; Hamon, S; Paccard, C; Parrino, J; Adelsberg, J van; Graham, NM; Penn, J; Lopez, A; Reid, J; Overton, J; Baras, A; Shuldiner, AR; Paulding, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. Issue 3 (9th June 2017) Authors: Luzum, JA; Pakyz, RE; Elsey, AR; Haidar, CE; Peterson, JF; Whirl‐Carrillo, M; Handelman, SK; Palmer, K; Pulley, JM; Beller, M; Schildcrout, JS; Field, JR; Weitzel, KW; Cooper‐DeHoff, RM; Cavallari, LH; O'Donnell, PH; Altman, RB; Pereira, N; Ratain, MJ; Roden, DM Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 3(2017) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗